Diagnostic relevance of 2‐[ <sup>18</sup> F]‐FDG PET/CT in patients recently diagnosed with monoclonal gammopathy of undetermined significance-Reference-Cited by-同舟云学术

Diagnostic relevance of 2‐[ ¹⁸ F]‐FDG PET/CT in patients recently diagnosed with monoclonal gammopathy of undetermined significance

Published:2022-10-17 Issue: Volume: Page:
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Rudolphi‐Solero Teodoro¹²^ORCID,Triviño‐Ibáñez Eva María²³,González‐Jiménez Antonio Daniel¹,Ramos‐Font Carlos²³,Ríos‐Tamayo Rafael⁴,Rebollo‐Aguirre Angel Custodio⁵,Sánchez‐Sánchez Rocío²³

Affiliation:

1. Servicio de Medicina Nuclear Complejo Hospitalario de Jaén Jaén Spain

2. Instituto de Investigación Biosanitaria ibs‐GRANADA Granada Spain

3. Servicio de Medicina Nuclear Hospital Universitario Virgen de las Nieves Granada Spain

4. Servicio de Hematología Hospital Universitario Virgen de las Nieves Granada Spain

5. Servicio de Medicina Nuclear Hospital Juan Ramón Jiménez Huelva Spain

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3085

Reference20 articles.

1. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EANM guidelines on the use of [18F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders;European Journal of Nuclear Medicine and Molecular Imaging;2024-08-29

2. Monoclonal Gammopathy of Clinical Significance (MGCS) and Related Disorders: A Review and the Role of Imaging;Diagnostics;2024-08-29

3. Monoclonal Gammopathies;Comprehensive Hematology and Stem Cell Research;2024